Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jennifer Sue Temel, M.D.

Co-Author

This page shows the publications co-authored by Jennifer Temel and Inga Lennes.
Connection Strength

3.377
  1. Greer JA, Jacobs JM, Pensak N, Nisotel LE, Fishbein JN, MacDonald JJ, Ream ME, Walsh EA, Buzaglo J, Muzikansky A, Lennes IT, Safren SA, Pirl WF, Temel JS. Randomized Trial of a Smartphone Mobile App to Improve Symptoms and Adherence to Oral Therapy for Cancer. J Natl Compr Canc Netw. 2020 02; 18(2):133-141.
    View in: PubMed
    Score: 0.239
  2. Nipp RD, El-Jawahri A, Moran SM, D'Arpino SM, Johnson PC, Lage DE, Wong RL, Pirl WF, Traeger L, Lennes IT, Cashavelly BJ, Jackson VA, Greer JA, Ryan DP, Hochberg EP, Temel JS. The relationship between physical and psychological symptoms and health care utilization in hospitalized patients with advanced cancer. Cancer. 2017 Dec 01; 123(23):4720-4727.
    View in: PubMed
    Score: 0.204
  3. El-Jawahri A, Moran SM, D'Arpino S, Johnson C, Lage DE, Wong R, Xiao Y, VanDusen H, Pirl WF, Traeger L, Lennes IT, Cashavelly BJ, Martinson HS, Jackson VA, Greer JA, Ryan DP, Hochberg EP, Temel JS. Symptom burden to predict health care utilization in hospitalized patients with incurable cancer. J Clin Oncol. 2016 Oct 09; 34(26_suppl):98.
    View in: PubMed
    Score: 0.190
  4. Pirl WF, Greer JA, Irwin K, Lennes IT, Jackson VA, Park ER, Fujisawa D, Wright AA, Temel JS. Processes of discontinuing chemotherapy for metastatic non-small-cell lung cancer at the end of life. J Oncol Pract. 2015 May; 11(3):e405-12.
    View in: PubMed
    Score: 0.171
  5. Greer JA, Irwin K, Lennes IT, Jackson VA, Park ER, Fujisawa D, Wright AA, Temel JS. Processes of discontinuing chemotherapy for metastatic non-small cell lung cancer at the end of life. J Clin Oncol. 2014 Nov; 32(31_suppl):96.
    View in: PubMed
    Score: 0.166
  6. Azzoli CG, Engelman J, Fidias P, Gainor JF, Heist RS, Lamont EB, Lennes IT, Rosovsky RP, Sequist LV, Shaw AT, Temel JS. Genotyping lung cancer is an investment in the future. J Clin Oncol. 2014 Nov 01; 32(31):3576-7.
    View in: PubMed
    Score: 0.164
  7. Greer JA, Pirl WF, Jackson VA, Muzikansky A, Lennes IT, Gallagher ER, Prigerson HG, Temel JS. Perceptions of health status and survival in patients with metastatic lung cancer. J Pain Symptom Manage. 2014 Oct; 48(4):548-57.
    View in: PubMed
    Score: 0.159
  8. El-Jawahri A, Traeger L, Park ER, Greer JA, Pirl WF, Lennes IT, Jackson VA, Gallagher ER, Temel JS. Associations among prognostic understanding, quality of life, and mood in patients with advanced cancer. Cancer. 2014 Jan 15; 120(2):278-85.
    View in: PubMed
    Score: 0.154
  9. Pirl WF, Traeger L, Greer JA, Jackson V, Lennes IT, Gallagher E, Sequist L, Temel JS. Depression, survival, and epidermal growth factor receptor genotypes in patients with metastatic non-small cell lung cancer. Palliat Support Care. 2013 Jun; 11(3):223-9.
    View in: PubMed
    Score: 0.147
  10. Temel JS, Greer JA, Gallagher ER, Jackson VA, Lennes IT, Muzikansky A, Park ER, Pirl WF. Electronic prompt to improve outpatient code status documentation for patients with advanced lung cancer. J Clin Oncol. 2013 Feb 20; 31(6):710-5.
    View in: PubMed
    Score: 0.146
  11. Lennes IT, Temel JS, Hoedt C, Meilleur A, Lamont EB. Predictors of newly diagnosed cancer patients' understanding of the goals of their care at initiation of chemotherapy. Cancer. 2013 Feb 01; 119(3):691-9.
    View in: PubMed
    Score: 0.143
  12. Pirl WF, Greer JA, Traeger L, Jackson V, Lennes IT, Gallagher ER, Perez-Cruz P, Heist RS, Temel JS. Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care. J Clin Oncol. 2012 Apr 20; 30(12):1310-5.
    View in: PubMed
    Score: 0.138
  13. Greer JA, Pirl WF, Jackson VA, Muzikansky A, Lennes IT, Heist RS, Gallagher ER, Temel JS. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol. 2012 Feb 01; 30(4):394-400.
    View in: PubMed
    Score: 0.136
  14. Pirl WF, Traeger L, Greer JA, Bemis H, Gallagher E, Lennes I, Sequist L, Heist R, Temel JS. Tumor epidermal growth factor receptor genotype and depression in stage IV non-small cell lung cancer. Oncologist. 2011; 16(9):1299-306.
    View in: PubMed
    Score: 0.132
  15. Lennes IT, Temel JS, Greer JA, Jacobson JO, Park ER, Jackson VA, Gallagher ER, Bemis H, Pirl WF. ASCO Quality Oncology Practice Initiative (QOPI) quality measures for smoking cessation and survival in metastatic NSCLC. J Clin Oncol. 2011 May 20; 29(15_suppl):6074.
    View in: PubMed
    Score: 0.130
  16. Pirl WF, Greer JA, Gallagher ER, Jackson VA, Lennes IT, Temel JS. Early palliative care, depression, and survival in metastatic NSCLC. J Clin Oncol. 2011 May 20; 29(15_suppl):6024.
    View in: PubMed
    Score: 0.130
  17. Greer JA, Pirl WF, Jackson VA, Lennes IT, Heist RS, Gallagher ER, Temel JS. Effect of early palliative care on chemotherapy utilization and end-of-life care in patients with metastatic non-small cell lung cancer (NSCLC). J Clin Oncol. 2011 May 20; 29(15_suppl):6009.
    View in: PubMed
    Score: 0.130
  18. Temel JS, Greer JA, Admane S, Gallagher ER, Jackson VA, Lynch TJ, Lennes IT, Dahlin CM, Pirl WF. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol. 2011 Jun 10; 29(17):2319-26.
    View in: PubMed
    Score: 0.130
  19. Jacobs JM, Ream ME, Pensak N, Nisotel LE, Fishbein JN, MacDonald JJ, Buzaglo J, Lennes IT, Safren SA, Pirl WF, Temel JS, Greer JA. Patient Experiences With Oral Chemotherapy: Adherence, Symptoms, and Quality of Life. J Natl Compr Canc Netw. 2019 03 01; 17(3):221-228.
    View in: PubMed
    Score: 0.056
  20. Swan JS, Lennes IT, Stump NN, Temel JS, Wang D, Keller L, Donelan K. A Patient-Centered Utility Index for Non-Small Cell Lung Cancer in the United States. MDM Policy Pract. 2018 Jul-Dec; 3(2):2381468318801565.
    View in: PubMed
    Score: 0.055
  21. Dagogo-Jack I, Azzolli CG, Fintelmann F, Mino-Kenudson M, Farago AF, Gainor JF, Jiang G, Piotrowska Z, Heist RS, Lennes IT, Temel JS, Mooradian MJ, Lin JJ, Digumarthy SR, Batten JM, Robinson H, Nose V, Rivera M, Nardi V, Dias-Santagata D, Le LP, Sequist LV, Pitman M, Shepard JO, Shaw AT, Iafrate AJ, Lennerz JK. Clinical Utility of Rapid EGFR Genotyping in Advanced Lung Cancer. JCO Precis Oncol. 2018; 2018.
    View in: PubMed
    Score: 0.054
  22. Piotrowska Z, Stirling K, Heist R, Campo M, Rizzo C, Digumarthy SR, Lanuti M, Fintelmann FJ, Lennes I, Farago A, Gainor J, Azzoli CG, Temel J, Mino-Kenudson M, Dias-Santagata D, Corcoran R, Shaw A, Engelman JA, Hata A, Sequist LV. Heterogeneity and Variation in Resistance Mechanisms Among 223 Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Patients With > 1 Post-Resistance Biopsy. Int J Radiat Oncol Biol Phys. 2017 May 01; 98(1):220.
    View in: PubMed
    Score: 0.049
  23. Jacobs JM, Pensak NA, Sporn NJ, MacDonald JJ, Lennes IT, Safren SA, Pirl WF, Temel JS, Greer JA. Treatment Satisfaction and Adherence to Oral Chemotherapy in Patients With Cancer. J Oncol Pract. 2017 05; 13(5):e474-e485.
    View in: PubMed
    Score: 0.049
  24. Greer JA, Amoyal N, Nisotel L, Fishbein JN, MacDonald J, Stagl J, Lennes I, Temel JS, Safren SA, Pirl WF. A Systematic Review of Adherence to Oral Antineoplastic Therapies. Oncologist. 2016 Mar; 21(3):354-76.
    View in: PubMed
    Score: 0.045
  25. El-Jawahri A, Pirl WF, Traeger L, Kumar P, Ryan DP, Lennes IT, Cashavelly BJ, Martinson HS, VanDusen H, Hochberg EP, Jackson VA, Greer JA, Temel JS, Nipp RD. Symptom burden in hospitalized patients with advanced cancer. J Clin Oncol. 2015 Oct 10; 33(29_suppl):100.
    View in: PubMed
    Score: 0.044
  26. Fujisawa D, Temel JS, Traeger L, Greer JA, Lennes IT, Mimura M, Pirl WF. Psychological factors at early stage of treatment as predictors of receiving chemotherapy at the end of life. Psychooncology. 2015 Dec; 24(12):1731-7.
    View in: PubMed
    Score: 0.043
  27. Greer JA, Lennes IT, Gallagher ER, Temel JS, Pirl WF. Documentation of oral versus intravenous chemotherapy plans in patients with metastatic non-small-cell lung cancer. J Oncol Pract. 2014 Mar; 10(2):e103-6.
    View in: PubMed
    Score: 0.039
  28. Sequist LV, Heist RS, Shaw AT, Fidias P, Rosovsky R, Temel JS, Lennes IT, Digumarthy S, Waltman BA, Bast E, Tammireddy S, Morrissey L, Muzikansky A, Goldberg SB, Gainor J, Channick CL, Wain JC, Gaissert H, Donahue DM, Muniappan A, Wright C, Willers H, Mathisen DJ, Choi NC, Baselga J, Lynch TJ, Ellisen LW, Mino-Kenudson M, Lanuti M, Borger DR, Iafrate AJ, Engelman JA, Dias-Santagata D. Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice. Ann Oncol. 2011 Dec; 22(12):2616-2624.
    View in: PubMed
    Score: 0.034
  29. Greer JA, Solis JM, Temel JS, Lennes IT, Prigerson HG, Maciejewski PK, Pirl WF. Anxiety disorders in long-term survivors of adult cancers. Psychosomatics. 2011 Sep-Oct; 52(5):417-23.
    View in: PubMed
    Score: 0.033
  30. Heist RS, Duda GD, Sahani D, Ancukiewicz M, Fidias P, Sequist LV, Shaw AT, Temel JS, Lennes IT, Neal JW, Pennell NA, Lynch TJ, Engelman JA, Jain RK. Phase II trial of carboplatin, abraxane, and bevacizumab in NSCLC. J Clin Oncol. 2011 May 20; 29(15_suppl):e18016.
    View in: PubMed
    Score: 0.033
  31. Sequist LV, Heist RS, Shaw AT, Fidias P, Temel JS, Lennes IT, Bast E, Waltman BA, Lanuti M, Muzikansky A, Mino-Kenudson M, Iafrate AJ, Borger DR, Dias-Santagata D, Engelman JA. SNaPshot genotyping of non-small cell lung cancers (NSCLC) in clinical practice. J Clin Oncol. 2011 May 20; 29(15_suppl):7518.
    View in: PubMed
    Score: 0.033
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.